08/11/2014 - 11:15am

Sanofi on Monday acquired the rights to Afrezza Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with Type 1 and Type 2 diabetes, from MannKind in a deal that could be worth as much as $925 million. 

08/06/2014 - 1:02pm

BD Medical, a segment of BD, on Wednesday announced the retail pharmacy launch of BD AutoShield Duo, the only pen needle with patented dual front- and back-end shields that provides greater convenience and safety before and after injecting. 

08/01/2014 - 12:07pm

The Food and Drug Administration announced approval for Boehringer Ingelheim's Jardiance tablets.

07/30/2014 - 10:32am

GSK announced that Tanzeum (albiglutide), a once-weekly, prescription injectable treatment for Type 2 diabetes in adults, is now available in pharmacies throughout the United States.

07/16/2014 - 1:18pm

HelpAround on Wednesday launched a mobile platform for people with diabetes — and their friends, family and caregivers — that reveals fellow ‘diabetes helpers’ from the crowd, helping people resolve sudden health crises, such as getting caught without essential over-the-counter blood glucose test strips.

07/15/2014 - 11:09am

Novartis has entered into an agreement with a division of Google to in-license its “smart lens” technology for all ocular medical uses. 

07/07/2014 - 10:00am

The American Diabetes Association on Monday announced its collaboration with Walgreens, a national strategic partner of the association, and the Balance Rewards program to help further the movement to Stop Diabetes.

07/02/2014 - 12:17pm

Larry Hausner, CEO of the American Diabetes Association, on Tuesday announced that he will step down as CEO, effective July 31, 2014, to pursue new opportunities in his native New York metro area.

06/30/2014 - 10:31am

Afrezza, an inhaled insulin powder meant to treat diabetes patients, was approved Friday by the Food and Drug Administration.